Advanced colorectal cancer in the elderly: Results of consecutive trials with 5-fluorouracil-based chemotherapy

Cancer Chemotherapy and Pharmacology

Volumn 42, Issue 4, 1998, Pages 336-340

  Chiara, Silvana ^a   Nobile, Maria Teresa ^a   Vincenti, Maura ^a   Lionetto, Rita ^a   Gozza, Alberto ^a   Barzacchi, Maria Cristina ^a   Sanguineti, Ornella ^a   Repetto, Lazzaro ^a   Rosso, Riccardo ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

5 Fluorouracil; Activity; Colorectal cancer; Elderly; Toxicity

Indexed keywords

FLUOROURACIL; FOLINIC ACID;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; CONJUNCTIVITIS; DIARRHEA; DRUG EFFICACY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; METASTASIS; NAUSEA; NEUROTOXICITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SKIN TOXICITY; STOMATITIS; THROMBOCYTOPENIA; VOMITING;

ADMINISTRATION, ORAL; ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLORECTAL NEOPLASMS; DIARRHEA; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLUOROURACIL; HUMANS; INFUSIONS, INTRAVENOUS; LEUCOVORIN; MALE; MIDDLE AGED; NAUSEA; QUALITY OF LIFE; RETROSPECTIVE STUDIES; STOMATITIS;

EID: 0031823713     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050826     Document Type: Article

References (18)

1. Hryniuk W, Bush H (1984) The importance of dose intensity in chemotherapy of metastatic breast cancer. J Clin Oncol 2: 1281
2. Litchman SM, Bayer RL (1997) Gastrointestinal cancer in the elderly. In: Whitaker K (ed), Balducci L (Guest ed) Clinics in geriatric medicine. Cancer in the elderly part II. W.B. Saunders Company, Philadelphia, p 307
3. Macdonald JS on behalf the International Working Group in Colorectal Cancer (1996) A study of the treatment and management of advanced colorectal cancer: the colorectal care pathway review (abstract 563). Proc Am Soc Clin Oncol 15: 230
4. Miller AB, Hoogstraten B, Staquet M, Winkler A (1981) Reporting results of cancer treatment. Cancer 47: 207
5. Newcomb PA, Carbone PP (1993) Cancer treatment and age: patient perspectives. J Natl Cancer Inst 85: 1580
6. Nobile MT, Rosso R, Sertoli MR, Rubagotti A, Vidili MG, Guglielmi A, Venturini M, Canobbio L, Fassio T, Gallo L, Galligioni E, Gallotti P, Bruzzi P, Sobrero A (1992) Randomised comparison of weekly bolus 5-fluorouracil with or without leucovorin in metastatic colorectal carcinoma. Eur J Cancer 11: 1823
7. Nobile MT, Barzacchi MC, Sanguineti O, Chiara S, Gozza A, Vincenti M, Lavarello A, Cognein P, Lionetto R, Percivale PL, Bertoglio S, Murolo C, Esposito M, Vannozzi MO, Rosso R (1998) Activity of high dose 24 hour 5-fluorouracil infusion plus L-leucovorin in advanced colorectal cancer. Anticancer Res 18: 517
8. Ozols RF, Thigpen JT, Dauplat J, Colombo N, Piccart MJ, Bertelsen K, Levin L, Lund B (1993). Dose intensity. Ann Oncol 4 [Suppl.4]: 49
9. Piedbois P, Buyse M, Rustum Y, Machover D, Erlichman C, Carlson RW, Valone F, Labianca R, Doroshow JH, Petrelli N (Writing Committee) for the Advanced Colorectal Cancer Meta-analysis Project (1992) Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. J Clin Oncol 10: 896
10. Piedbois P, Buyse M, Blijham G, Glimelius B, Herrmann R, Valone F, Carlson R, Machiavelli M, Delfino C, Abad A, and Petrelli N (Writing Committee) for the Advanced Colorectal Cancer Meta-analysis Project (1994) Meta-analysis of randomized trials testing the biochemical modulation of fluorouracil by methotrexate in metasiatic coloreclal cancer. J Clin Oncol 12: 960
11. Poon MA, O'Connell MJ, Moertel GG, Wieand HS, Culliman SA, Everson LK, Krook JE, Ailliard JA, Laurie JA, Tschetter LK, Wiesenfeld M (1989) Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma. J Clin Oncol 7: 1407
12. Scheithauer W, Rosen H, Kornek GV, Sebesta C, Depisch D (1993) Randomized comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer. BMJ 306: 752
13. Sobrero A, Guglielmi A, Aschele C, Tixi L, Bolli E, Mori A, Rosso R, Lionetto R, Bruzzi P (1994) Adjuvant chemotherapy of elderly patients with colorectal cancer. Proceedings Second International Conference on Geriatric Oncology Cancer in the Elderly Genoa, 19-21 September Tormena Industril Coroficle, Genoa, p. 111
14. Stein BN, Petrelli NJ, Douglass HO, Driscoll DL, Arcangeli G, Meropol NJ (1995) Age and Sex are independent predictors of 5-fluorouracil toxicity: analyses of a large scale phase II trial. Cancer 75: 11
15. Steinberg J, Erlichman C, Gadalla T, Fine S, Wong A (1992) Prognostic factors in patients with metastatic colorectal cancer receiving 5-fluorouracil and folinic acid. Eur J Cancer 28A: 1817
16. Tirelli U, Zagonel V, Serraino, Thomas J, Hoerni B, Tangury A, Ruhl U, Bey P, Tubiana N, Breed WPM, Roozendaal KJ, Hagenheek A, Hupperets PS, Somers R (1998) Non-Hodgkin lymphoma in 137 patients aged 70 years or older: a retrospective European Organization for Research and Treatment of Cancer Lymphoma Group study, J Clin Oncol 6: 1708
17. Yokes EE, Ratain MJ, Mick R, McEvilly JM, Haraf D, Kozloff M, Hamasaki V, Weichselbaum RR, Panje WR, Wenig B, Berezin F (1993) Cisplatin, fluorouracil, and leucovorin augmentated by interferon alta-2b in head and neck cancer: a clinical and pharmacologic analysis. J Clin Oncol 11: 360
18. Wood WC, Budman DR, Komm AH, Cooper MR, Younger J, Hart RD, Moore A, Ellerton JA, Norton L, Ferree CR, Ballow AC, Frei E III, Henderson C (1994) Dose and dose-intensity of adjuvant chemotherapy for stage II, node-positive breast carcinoma. N Engl J Med 330: 1253